Crizotinib for Previously Treated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer (TA422)

Everolimus with Exemestane for Treating Advanced Breast Cancer after Endocrine Therapy (TA421)

Nivolumab for Previously Treated Advanced Renal Cell Carcinoma (TA417)

Osimertinib for Treating Locally Advanced or Metastatic EGFR T790M Mutation-Positive Non-Small-Cell Lung Cancer (TA416)

Cobimetinib in Combination with Vemurafenib for Treating Unresectable or Metastatic BRAF V600 Mutation-Positive Melanoma (TA414)

Necitumumab for Untreated Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer (TA411)

Talimogene Laherparepvec for Treating Unresectable Metastatic Melanoma (TA410)

Pegaspargase for Treating Acute Lymphoblastic Leukaemia (TA408)

Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer (TA406)

Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer (TA405)

Load More